# Lactulose

## Duphalac 500mL\(667mg/mL\) oral solution

| 藥物代碼 | LDUP5 |
| :--- | :--- |
| 適應症 | Chronic portal systemic encephalopathy, hepatic pre coma, hepatic coma, Chronic constipation. |
| 副作用 | CommonGastrointestinal: Bloating symptom, Diarrhea, Epigastric pain, Flatulence, Nausea, VomitingMusculoskeletal: CrampSeriousEndocrine metabolic: Hypernatremia, Hypokalemia |
| 禁忌 | Galactosemia, Gastrointestinal perforation, Risk of gastrointestinal perforation. |
| 藥物保存方式 | 攝氏25度以下 |
| 用法用量 | Chronic constipation: adult: Initial: 10-45 mL; Maintain dose: 10-25 mL. 7-14 years old Children: Initial: 15 mL; Maintain dose: 10-15 mL. 1-6 years old Children: Initial: 5-10 mL; Maintain dose: 5-10 mL. infant: Initial: 5 mL; Maintain dose: 5 mL. Orally once daily in the morning. 24-48 hours may be required to produce a normal bowel movement. Hepatic encephalopathy: Initial dosage: 30-50 mL orally 2-3 times daily. Maintenance dosage: Adjust every day to achieve 2 to 3 soft formed stools daily. \[Micromedex 20210101\] Rectal route: Treatment and Prophylaxis of Hepatic encephalopathy: Usual dosage: Mix lactulose 300 mL with 700 mL water or NS and administer rectally via rectal balloon catheter; retain for 30 to 60 minutes. Repeat dosages: Enema may be repeated every 4 to 6 hours for reversal of coma stage; if inadvertently evacuated too promptly, repeat immediately. Conversion to oral: When the oral route is viable, initiate oral administration before rectal administration is terminated. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 尚未確立 |
| 孕期用藥建議 | No \(Limited\) Human Data - Probably Compatible |
| 附帶說明 | \[仿單\]懷孕期間使用本品預期不會對胎兒造成影響,因lactulose再懷孕婦女之全身性暴露量極微. 因此,懷孕期間可使用本品.在現有的數據中無畸形或胎兒/新生兒毒性. 動物試驗中無顯示直接或間接對懷孕,胚胎/新生兒發展,分娩或產後發展有害. |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | \[仿單\]本品對母乳餵養的新生兒或嬰兒預期無任何影響, 因lactulose在授乳婦女之全身性暴露量極微. 因此,授乳期間可使用本品. |
| 注射劑給藥建議途徑 | AC, PC, PO, RECT, WM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

